NCT06089356Recruiting
Zolmitriptane as Prophylaxis for Chilhood Migraine
Zolmitriptane as Prophylactic Therapy Childhood Migraine
Tanta UniversityPhase 4ClinicalTrials.govdrug
Study focus
- Disease/Condition
- Migraine
- Drug/Device/Intervention
- zolmitriptanee
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Tanta University
- Location
- Tanta, Egypt
Timeline & enrollment
- Phase
- Phase 4
- Start date
- Jan 01, 2023
- End date
- Jan 01, 2024
- Enrollment
- 90 participants
Primary outcome
number and severity of migraine attacks
Summary
zolmitriptane can be tried as prophylactic therapy of childhood migraine
ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06089356
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06089356 through Pure Global AI's free database. This Phase 4 trial is sponsored by Tanta University and is currently Recruiting. The study focuses on Migraine. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.